Researchers scour nordic health records to gauge safety of MS drug for pregnant women
NCT ID NCT06053749
Summary
This study aims to find out if enough pregnant women with Multiple Sclerosis (MS) in Finland and Sweden used the medication interferon-beta during their second and third trimesters. Researchers are analyzing existing health records to count these cases. The goal is to determine if there are enough cases to launch a proper safety study on pregnancy outcomes for mothers taking this MS drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, MS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many locations
Multiple Locations, Finland
-
Many locations
Multiple Locations, Sweden
Conditions
Explore the condition pages connected to this study.